Zack King

CEO & FOUNDER

As CEO of SHYFT Analytics, Zack is passionate about fully realizing the company’s vision delivering transformative insights to the global life sciences and healthcare industries.  He is responsible for the company’s overall strategy, sales and product advancement.

With over sixteen years experience managing technology companies, Zack has spent much of his career creating innovative solutions for clients such as Gillette, Johnson & Johnson, and a number of start-ups. Zack was an early employee at ZEFER, a software services firm that raised $160M in funding and grew to over $100M in revenue, 800 people, and six global offices. Prior to ZEFER, he lead global software engineering and product teams at EF Education First, the world’s largest private education company. During the Gulf War, Zack served in the United States Army with the 101st Airborne Division, was awarded the elite Air Assault designation and the Army Commendation Medal for heroism and meritorious achievement after which he attended Bentley University’s Computer Information Systems program.

David Tamburri

Director

Dave is a general Partner with Health Enterprise Partners, a growth equity firm focused on health care services and information technology companies. Prior to joining HEP, Dave was a Vice President with Susquehanna Growth Equity, a private equity group focused on growth capital opportunities in the technology sector. He was formerly the President and Chief Operating Officer at Onward Healthcare, Inc., a provider of human capital services to healthcare providers sponsored by Welsh, Carson, Anderson, & Stowe. As an Executive Vice President with Pinnacor, Inc., a provider of information and analytical applications, Dave managed the company’s worldwide operations. Pinnacor completed an IPO in 2000 and was later sold to CBS Marketwatch.

Dave is on the boards of eVariant, Nordic Consulting, Privia Health, SHYFT Analytics, and Vitals. He served as a director of MobileMD prior to the company’s sale to Siemens. He serves on the board of The Open Door Shelter, and since 2000, he has been a Lecturer at Columbia University in the Executive Master of Science in Technology Management program.

Dave is a distinguished graduate of the United States Military Academy (1993) and holds an MBA from Harvard Business School (1999).

Steven Hirschfeld

Director

Steve brings more than 25 years of customer-facing executive management experience in healthcare and technology to his position as Chief Commercial Officer of Medidata Solutions. In this role, he is responsible for Medidata’s Global Sales & Alliance organization, Value Office and Strategic Business Development.

In more than a decade of continuous service with Medidata, Steve has been instrumental in the company’s growth. His track record includes a series of progressive roles including executive management of many of Medidata’s key Commercial and Operational organizations. His contributions have played an instrumental role in the company’s IPO in 2009 and current market cap of $2.5 billion.

Previously, Steve served as vice president of sales at I-Many, helping to prepare its successful IPO in July 2000, and spent five years as a business development executive for the Janis Group.

Steve received his BS from the University of Delaware.

John Corcoran

Director

John has over 20 years experience in pharmaceuticals and biotechnology with particular interests in commercialization strategy, data management, and analytics. He is the Founder and President of Trinity Partners, a life sciences consulting firm.

Previously, John co-founded Soteira, a venture-backed medical device company that pioneered innovative solutions for treating vertebral compression fractures caused by osteoporosis, cancer, and traumatic injuries. John also co-founded biotech communications software company, AkutaLabs, and Odyl, LLC, a New York-based social media platform company. John is on the board of directors of the Sports Legacy Institute, a Boston-based non-profit that is studying the effects of concussions and other sports related brain injuries on athletes worldwide.

John graduated from Harvard College and has graduate degrees from the Kennedy School at Harvard and Northeastern.

Michael Weintraub

Director

Michael is Managing Partner of Optum Ventures, focused on digital health innovation. Previously, he was Co-Founder and CEO of Humedica, acquired by UnitedHealth Group (UHG) in 2013.

Michael broadened his role within UHG as President and CEO of Optum Analytics. Prior to launching Humedica, he served as Senior Managing Director at Leerink Partners, a leading health care investment bank. Previously, Michael was President and CEO of PHARMetrics, a health care informatics company, which was successfully sold to IMS Health in 2005. He serves as Founding Chairman of the Board of Phreesia, a digital health company that develops automated patient engagement solutions. Michael is on the Board of Directors of Shyft Analytics, a company providing cloud data management and analytics solutions for global life sciences.

He is on the Board of Directors of Mindstrong, a company transforming the diagnosis and treatment of behavioral health disorders through ubiquitous mobile technology. Michael is an Advisory Board member of the Innovation and Digital Health Accelerator at Boston Children’s Hospital. He serves as a mentor and speaker at the Harvard Innovation Lab (iLab), a unique collaboration and education space designed to foster entrepreneurship. Michael is a member of the Board of Directors of Juvenile Diabetes Research Foundation (JDRF) New England Chapter; as well as The College Diabetes Network (CDN), whose mission is to empower and improve the lives of students living with Type 1 diabetes through peer support and access to information and resources. He is a past Board member of AMGA Analytics, the informatics subsidiary of the American Medical Group Association (AMGA), having served on the Board for seven years. Michael received his MBA from Harvard Business School and his bachelor’s degree in Economics from Brandeis University.